Predicting anti-HIV-1 activity of 6-arylbenzonitriles: computational approach using superaugmented eccentric connectivity topochemical indices.

Highly discriminating adjacency-cum-distance based topochemical indices termed as superaugmented eccentric connectivity topochemical indices for quantitative structure-activity and structure-property relationships (QSAR/QSPR) have been conceptualized in the present study. These indices were found to exhibit high sensitivity towards the presence and relative position of heteroatom(s), exceptionally high discriminating power and negligible degeneracy for all possible structures of five vertices containing one heteroatom. Utility of these indices was investigated for development of models for prediction of anti-human immunodeficiency virus (HIV)-1 activity using a data set comprising 81 differently substituted 6-arylbenzonitriles. The values of the superaugmented eccentric connectivity topochemical indices of all the analogues comprising the data set were computed using an in-house computer program. The resultant data was analyzed and suitable models were developed after identification of the active ranges. Subsequently, a biological activity was assigned to each analogue using these models which was then compared with the reported anti-HIV-1 activity. The accuracy of prediction was found to be approximately 81% for all the three topochemical models. High sensitivity towards presence and relative position of heteroatom(s), exceptionally high discriminating power amalgamated with low degeneracy offer proposed topochemical indices vast potential for isomer discrimination, similarity/dissimilarity, drug design, quantitative structure-activity/structure-property relationships, lead optimization and combinatorial library design.

[1]  Subhash C. Basak,et al.  Use of Topostructural, Topochemical, and Geometric Parameters in the Prediction of Vapor Pressure: A Hierarchical QSAR Approach , 1997, J. Chem. Inf. Comput. Sci..

[2]  D W Barry,et al.  3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J P Doucet,et al.  Application of topological descriptors in QSAR and drug design: history and new trends. , 2002, Current drug targets. Infectious disorders.

[4]  Ernesto Estrada,et al.  From molecular graphs to drugs. A review on the use of topological indices in drug design and discovery , 2003 .

[5]  E Uriarte,et al.  Recent advances on the role of topological indices in drug discovery research. , 2001, Current medicinal chemistry.

[6]  Chemotherapeutic approaches to the treatment of the acquired immune deficiency syndrome (AIDS). , 1986 .

[7]  Ovidiu Ivanciuc,et al.  Four New Topological Indices Based on the Molecular Path Code , 2007, J. Chem. Inf. Model..

[8]  Alexandru T. Balaban,et al.  Using real numbers as vertex invariants for third-generation topological indexes , 1992, J. Chem. Inf. Comput. Sci..

[9]  Ernesto Estrada,et al.  Extended Wiener indices. A new set of descriptors for quantitative structure-property studies , 1998 .

[10]  Douglas J. Klein,et al.  Wiener Index Extension by Counting Even/Odd Graph Distances , 2001, J. Chem. Inf. Comput. Sci..

[11]  R. Musah.  The HIV-1 nucleocapsid zinc finger protein as a target of antiretroviral therapy. , 2004, Current topics in medicinal chemistry.

[12]  R. Pauwels,et al.  Evolution of anti-HIV drug candidates. Part 3: Diarylpyrimidine (DAPY) analogues. , 2001, Bioorganic & medicinal chemistry letters.

[13]  John P. Moore,et al.  New targets for inhibitors of HIV-1 replication , 2000, Nature Reviews Molecular Cell Biology.

[14]  E. Clercq,et al.  Acyclic nucleoside phosphonates: a key class of antiviral drugs , 2005, Nature Reviews Drug Discovery.

[15]  H. Mitsuya,et al.  Strategies for antiviral therapy in AIDS , 1987, Nature.

[16]  Kunal Roy,et al.  Topological descriptors in drug design and modeling studies , 2004, Molecular Diversity.

[17]  A. K. Madan,et al.  Model for Prediction of Anti‐HIV Activity of 2‐Pyridinone Derivatives Using Novel Topological Descriptor , 2006 .

[18]  E. Clercq.  Novel compounds in preclinical/early clinical development for the treatment of HIV infections. , 2000 .

[19]  A. K. Madan,et al.  Predicting anti-HIV activity: computational approach using a novel topological descriptor , 2001, J. Comput. Aided Mol. Des..

[20]  D. Covell,et al.  Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers. , 1999, Journal of medicinal chemistry.

[21]  S D Kemp,et al.  Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). , 1989, Science.

[22]  D. Richman,et al.  HIV drug resistance. , 1992, AIDS research and human retroviruses.

[23]  A. Madan,et al.  Prediction of h5-HT2A receptor antagonistic activity of arylindoles: computational approach using topochemical descriptors. , 2006, Journal of molecular graphics & modelling.

[24]  D I Stuart,et al.  2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1. , 2001, Journal of medicinal chemistry.